Cerus Gets CE Mark for Intra-Cranial Aneurysm Device

Cerus Endovascular received the European Union’s CE Mark for its Contour Neurovascular System.

The device, used to treat intra-cranial aneurysms through an implant.

Cerus is currently conducting a 45-patient single-arm trial to demonstrate the device’s safety in treating unruptured aneurysms, with the research taking place at four neurological centers in the United Kingdom and one in Hungary.

The Contour system will receive a limited commercial rollout in the third quarter of this year.